by administrator | Jan 9, 2018 | News, TREVENTIS
See original article here PARIS and TORONTO, Jan. 4, 2018 /PRNewswire/ — Servier and Treventis announce strategic research partnership in targeting misfolded proteins implicated in neurodegenerative diseases. The collaboration covers a large drug discovery...
